8 Recruiting Studies Using Entinostat
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Entinostat
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
📍 USC / Norris Comprehensive Cancer Center — Los Angeles, California
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Anatomic Stage III Breast Cancer AJCC v8
View Study & Checklist ➔Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
📍 Northwestern University (Data Collection Only) — Evanston, Illinois
Lymphoma
View Study & Checklist ➔A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Oropharyngeal Cancer
View Study & Checklist ➔Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Anatomic Stage III Breast Cancer AJCC v8
View Study & Checklist ➔Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Bladder Cancer
View Study & Checklist ➔High Dose IL 2 and Entinostat in RCC
📍 Univeristy of Southern California — Los Angeles, California
Renal Cell Carcinoma
View Study & Checklist ➔Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
📍 Yale University — New Haven, Connecticut
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔